Diazepam treatment of early signs of exacerbation in schizophrenia

American Journal of Psychiatry

Volumn 156, Issue 2, 1999, Pages 299-303

  Carpenter Jr , William T ^a   Buchanan, Robert W ^b   Kirkpatrick, Brian ^b   Breier, Alan F ^b  

^a MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT; DIAZEPAM; FLUPHENAZINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCHIZOPHRENIA; SINGLE BLIND PROCEDURE;

ACUTE DISEASE; ADULT; AGE OF ONSET; ANTI-ANXIETY AGENTS; ANTIPSYCHOTIC AGENTS; DIAZEPAM; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FLUPHENAZINE; HUMANS; MALE; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME;

EID: 0344527721     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Johns CA, Thompson JW: Adjunctive treatments in schizophrenia: pharmacotherapies and electroconvulsive therapy. Schizophr Bull 1995; 21:607-619
2. Kane JW: Schizophrenia. N Engl J Med 1996; 334:34-41
3. Christison GW, Kirch DG, Wyatt RJ: When symptoms persist: choosing among alternative somatic treatments for schizophrenia. Schizophr Bull 1991; 17:217-245
4. Meltzer HY: Treatment of the neuroleptic-nonresponsive schizophrenic patient. Schizophr Bull 1995; 18:515-542
5. Siris SG, Adan F, Cohen M, Mandeli J, Aronson A, Fdasono-Dube B: Targeted treatment of depression-like symptoms in schizophrenia. Psychopharmacol Bull 1987; 23:85-89
6. Siris SG, Bermanzohn PC, Mason SE, Shuwall MA: Anti-depressant for substance abusing schizophrenia patients: a mini-review. Prog Neuropsychopharmacol Biol Psychiatry 1991; 15:1-13
7. Buchanan RW, Brandes M, Breier A: Treating negative symptoms: pharmacological strategies, in The New Pharmacotherapy of Schizophrenia. Edited by Breier A. Washington, DC, American Psychiatric Press, 1996, pp 179-204
8. Goff DC, Tsai G, Manoach DS, Coyle JT: Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia. Am J Psychiatry 1995; 152:1213-1215
9. Javitt DC, Zylberman I, Zukin SR, Heresco-Levy U, Lindenmayer J-P: Amelioration of negative symptoms in schizophrenia by glycine. Am J Psychiatry 1994; 151:1234-1236
10. Leiderman E, Zylberman I, Zukin SR, Cooper TB, Javitt DC: Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open label trial. Biol Psychiatry 1996; 39:213-215
11. Heresco-Levy U, Javitt DC, Irmilov M, Mordel C. Horowitz A, Kelly D: Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia. Br J Psychiatry 1996; 169:610-617
12. Norman RMG, Malla AK: Prodromal symptoms of relapse in schizophrenia: a review. Schizophr Bull 1995; 21:527-539
13. Herz MI, Melville C: Relapse in schizophrenia. Am J Psychiatry 1980; 137:801-805
14. Heinrichs DW, Carpenter WT: Prospective study of prodromal symptoms in schizophrenic relapse. Am J Psychiatry 1985; 142:371-373
15. Bustillo J, Buchanan RW, Carpenter WT: Prodromal symptoms vs early warning signs and clinical action in schizophrenia. Schizophr Bull 1995; 21:553-561
16. van Kammen DP: γ-Aminobutyric acid (Gaba) and the dopamine hypothesis of schizophrenia. Am J Psychiatry 1977; 134:138-143; correction, 134:463-464
17. Wolkowitz OM, Pickar D: Benzodiazepines in the treatment of schizophrenia: a review and reappraisal. Am J Psychiatry 1991; 148:714-726
18. Wolkowitz OM, Turetsky MA, Reus VI, Hargreaves WA: Benzodiazepine augmentation of neuroleptics in treatment-resistant schizophrenia. Psychopharmacol Bull 1992; 28:291-295
19. Kirkpatrick B, Buchanan RW, Waltrip RW, Jauch D, Carpenter WT: Diazepam treatment of early symptoms of schizophrenic relapse. J Nerv Ment Dis 1989; 177:52-53
20. Hawk AB, Carpenter WT, Strauss JS: Diagnostic criteria and five-year outcome in schizophrenia. Arch Gen Psychiatry 1975; 32:343-347
21. Carpenter WT, Heinrichs DW: Early intervention, time-limited targeted pharmacotherapy in schizophrenia. Schizophr Bull 1983; 9:533-542
22. Carpenter WT, Heinrichs DW, Hanlon TE: A comparative trial of pharmacologic strategies in schizophrenia: a comparative study of new approaches. Psychopharmacol Bull 1986; 22: 854-859
23. Carpenter WT Jr, Hanlon TE, Heinrichs DW, Summerfelt AT, Kirkpatrick B, Levine J, Buchanan RW: Continuous versus targeted medication in schizophrenic outpatients: outcome results. Am J Psychiatry 1990; 147:1138-1148
24. Schooler N: Antipsychotic medications in schizophrenia: their effect in acute and maintenance treatment, in Schizophrenia: Origins, Processes, Treatment and Outcome. Edited by Cromwell RL. New York, Oxford University Press, 1993, pp 284-295
25. Dixon LB, Lehman AF, Levine J: Conventional antipsychotic medications for schizophrenia. Schizophr Bull 1995; 21:567-577
26. Hogarty GE: Prevention of relapse in chronic schizophrenia patients. J Clin Psychiatry 1993; 54(March suppl): 18-23
27. Weiden PJ, Olfson M: Cost of relapse in schizophrenia. Schizophr Bull 1995; 21:419-429
28. Lehman AF, Steinwachs DM, Survey Co-Investigators of the PORT Project: Patterns of usual care for schizophrenia: initial results from the schizophrenia patient outcomes research team (PORT) client survey. Schizophr Bull 1998; 24:11-20
29. Weiss R: Volunteers at risk in medical studies: complex research projects strain system of safeguards. Washington Post, Aug 1, 1998, p A1
30. Carpenter WT, Schooler NR, Kane JM: The rationale and ethics of medication-free research in schizophrenia. Arch Gen Psychiatry 1997; 54:401-407
31. Schooler NR, Keith SJ, Severe JB, Matthews SM, Bellack AS, Glick ID, Hargreaves WA, Kane JM, Ninan PT, Frances A, Jacobs M, Lieberman JA, Mance R, Simpson GM, Woerner MG: Relapse and rehospitalization during maintenance treatment of schizophrenia. Arch Gen Psychiatry 1997; 54:453-464
32. Carpenter WT Jr, Heinrichs DW, Hanlon TE: A comparative trial of pharmacologic strategies in schizophrenia. Am J Psychiatry 1987; 144:1466-1470